BRIEF published on 11/01/2024 at 07:05, 20 days 6 hours ago ARYZTA Finalizes CHF325.4 Million Hybrid Bond Repurchase Repurchase Financial Strategy Capital Structure ARYZTA Hybrid Bond
PRESS RELEASE published on 11/01/2024 at 07:00, 20 days 7 hours ago ARYZTA completes repurchase of CHF325.4m Hybrid bond ARYZTA AG completes repurchase of CHF325.4m Hybrid bond. The international bakery company has a leadership position in convenience bakery with operations in Europe, Asia, Australia, and New Zealand Repurchase ARYZTA AG Convenience Bakery Bakery Company Hybrid Bond
BRIEF published on 10/24/2024 at 18:05, 27 days 19 hours ago ARYZTA Announces Executive Committee Changes Executive Committee Leadership Change ARYZTA AG Swiss Exchange Bakery Industry
PRESS RELEASE published on 10/24/2024 at 18:00, 27 days 20 hours ago ARYZTA announces changes to Executive Committee ARYZTA AG announces changes to Executive Committee. The international bakery company is headquartered in Schlieren, Switzerland, with operations globally Executive Committee Switzerland ARYZTA AG Global Baker
BRIEF published on 10/21/2024 at 07:05, 1 month ago ARYZTA AG Sees Rebound in Volume Growth, Maintains EBITDA Margin Target EBITDA Margin Organic Growth ARYZTA AG Convenience Bakery Volume Growth
PRESS RELEASE published on 10/21/2024 at 07:00, 1 month ago Volume growth rebounds, targeting full year organic growth at the lower end of the guidance, mid-term EBITDA margin target on track ARYZTA AG reports volume growth rebound with full year organic growth target at lower end of guidance. Mid-term EBITDA margin target remains on track EBITDA Margin Organic Growth Guidance ARYZTA AG Volume Growth
BRIEF published on 09/16/2024 at 07:05, 2 months 5 days ago ARYZTA to Redeem Outstanding CHF325.4m Hybrid Bond SIX Swiss Exchange Redemption ARYZTA Hybrid Bond CHF325.4m
PRESS RELEASE published on 09/16/2024 at 07:00, 2 months 5 days ago ARYZTA to redeem outstanding CHF325.4m Hybrid bond ARYZTA AG to redeem outstanding CHF325.4m Hybrid bond. ARYZTA, a bakery company, based in Schlieren, Switzerland, operates globally in convenience bakery sector ARYZTA AG Redeem Bakery Company Hybrid Bond Schlieren
BRIEF published on 08/12/2024 at 07:05, 3 months 9 days ago ARYZTA AG Reports Strong Profitability Progress and New Refinancing Agreement Profitability Refinancing Guidance ARYZTA Hybrid Bond
PRESS RELEASE published on 08/12/2024 at 07:00, 3 months 9 days ago Strong progress of profitability; New refinancing agreed - Hybrid bond buy-back; Guidance reiterated ARYZTA AG reports strong progress in profitability with new refinancing and hybrid bond buy-back. Reiterates guidance in the latest half-year results Profitability Refinancing Half-year Results Guidance ARYZTA AG
Published on 11/21/2024 at 13:30, 33 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 33 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 3 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 27 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 47 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 5 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 42 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 18 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 18 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
